Navigation Links
An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes

and will roll out throughout the U.S. in 2007. Every day, more than 4,000 people in the United States are newly diagnosed with diabetes, yet 58 percent of patients will receive no formal education about their disease. Merck is committed to improve patient care in diabetes through its significant pipeline of investigational diabetes compounds, currently marketed diabetes products (JANUVIA(TM) and JANUMET(TM)), and novel resources to support healthcare professionals and patients such as Journey for Control.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.com.

Merck forward-looking statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in the statements. The forward-looking statements may include statements regarding product development, product potential or financial performance. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the many uncertainties that affect Merck's business, particula
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:8/27/2015)... Aug. 27, 2015  Eli Lilly and Company (NYSE: ... Healthcare Conference on Thursday, September 17, 2015. Sue ... Lilly Oncology and Richard Gaynor , M.D., senior ... Lilly Oncology, will participate in a fireside chat at ... live audio webcast will be available on the "Webcasts ...
(Date:8/27/2015)... 27, 2015   Women Grow , the fastest-growing professional networking ... with the Cannabis World Congress & Business Exposition ... 15 business-focused educational sessions. CWCBExpo in LA will take place ... Convention Center in Los Angeles, CA ... Coast for the marijuana industry. The Women Grow ...
(Date:8/27/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), ... tissue and patent-protected processes to develop and market ... Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental ... multiple inaccuracies in the press release issued by ... rulings from the Patent Trial and Appeal Board ...
Breaking Medicine Technology:Lilly to Participate in Morgan Stanley Global Healthcare Conference 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 3Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 4MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4
... The Consumer Healthcare Products Association (CHPA), representing ... children, applauds the U.S. Food and Drug Administration ... their children the right amount of medicine. Today, ... Advisory Committee recommended enhancing the labels of all ...
... (NYSE: LLY ) today announced that David M. ... American Diabetes Association, has been named distinguished medical fellow for ... In his new role, Kendall will serve as ... clinical science communities and as a representative to the professional ...
Cached Medicine Technology:OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 2OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 3David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly 2David M. Kendall, M.D., Named Distinguished Medical Fellow at Lilly 3
(Date:8/27/2015)... ... , ... In an article published July 30th by the New ... Orleans, highlighting a security firm that is tasked with providing supplemental protection. Called the ... worked with the city to provide private security when it is needed in a ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... one of just 20 adult-only medical centers in the United States to receive ... hearts and lungs. The Extracorporeal Life Support Organization (ELSO) , an international ...
(Date:8/27/2015)... ... 27, 2015 , ... On May 30th, 2015, at the Adams County Fairgrounds ... the “Music With A Mission” benefit concert. For the past two years, “Music With ... underfunded school districts of Mendon and neighboring town, Quincy, IL. Organized in part by ...
(Date:8/27/2015)... WILMINGTON, Del. (PRWEB) , ... August 27, 2015 , ... ... Hospital, will be the guest speaker at CURE® magazine’s 3rd Annual MPN Heroes™ ... , Dr. Arnold will be among hundreds of attendees honoring eight heroes who have ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... , scheduled for October 27-29, 2015 in San Jose, CA. The first ... primarily focus on the void that exists where battery development and energy storage ...
Breaking Medicine News(10 mins):Health News:Article on New Orleans Security Force Highlights the Abilities and Flexibility of Private Security, says Spear Security Inc. 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:Best Drug Rehabilitation Interviews Madd Hoss Jackson at the 2015 "Music With A Mission" Benefit Concert 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 3Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 4Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2
... NY, October 6, 2010 In recognition of the 20th ... (ADA), the October issue of Disability and Health Journal ... whether the ADA has in fact improved the health of ... acknowledging physical barriers and need for better staff training and ...
... about unethical U.S. studies on syphilis in Guatemala in the ... has written a commentary for Bioethics Forum , the ... learn from history to better protect human subjects in the ... Wellesley College, describes how she unearthed documents about the study ...
... at the Johns Hopkins Bloomberg School of Public Health ... Reviewed Orthopaedic Research Program (PRORP) of the U.S. Department ... Research Consortium (METRC). The Consortium, which was established in ... DOD, conducts multi-center studies relevant to the treatment and ...
... Reinberg HealthDay Reporter , THURSDAY, Oct. 7 (HealthDay ... illness and help prevent the spread of flu, many Americans ... this coming season, new surveys reveal. Despite the attention ... Americans say they will not be getting the vaccine this ...
... ANN ARBOR, Mich.Clinical trials in which participants are randomly ... of clinical research. When conducted correctly, it,s widely accepted ... and can be trusted. But researchers ... process for bringing therapies and medical devices to patients ...
... AURORA, Colorado (Oct. 6, 2010) The University of Colorado ... University of Colorado School of Medicine, has been awarded $6.3 ... emphasis on donors from minority groups. The three-year ... division of the United States Department of Health and Human ...
Cached Medicine News:Health News:Disability and Health Journal critically examines Americans with Disabilities Act 2Health News:Disability and Health Journal critically examines Americans with Disabilities Act 3Health News:Disability and Health Journal critically examines Americans with Disabilities Act 4Health News:Additional $38M awarded to expand orthopedic trauma care research 2Health News:Many Americans Plan to Skip Flu Shot This Year 2Health News:Many Americans Plan to Skip Flu Shot This Year 3Health News:U-M receives NIH, FDA grant to study adaptive clinical trial designs 2Health News:University of Colorado gets federal award for Cord Blood Bank 2
... and negative whole blood control to test ... solubility tests and hemoglobin electrophoresis. Sickle-Chex is ... manufacturers' solubility kits. Sickle-Chex is packaged in ... vial dispenses an accurate sample volume. No ...
... three-part differential control assayed for all parameters on ... Series, AcT/AcT diff/AcT diff2, MD Series and ONYX ... 1800; ABX Micros 60; and Diatron Abacus and ... stability of 30 days and a six-month closed-vial ...
... Cell-Chex Auto is a whole blood ... of hematology instruments that measure automated blood ... The assay provides total RBC and WBC ... and Sapphire, Beckman Coulter LH750/LH 755 (levels ...
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Medicine Products: